Avoidant Restrictive Food Intake Disorder (ARFID) Nutritional Support Protocol

Avoidant/Restrictive Food Intake Disorder (ARFID) is an eating disorder characterized by limited food intake due to lack of interest in eating, sensory sensitivities to food (texture, taste, smell), or fear of negative consequences from eating (like choking or vomiting). Unlike anorexia nervosa, ARFID is not driven by body image concerns. It can affect children and adults, leading to nutritional deficiencies, weight loss or failure to grow, and significant impairment in daily life. ARFID is common in autism spectrum disorder and anxiety disorders.

CRITICAL: ARFID requires specialized treatment with professionals experienced in eating disorders. Treatment typically includes cognitive-behavioral therapy for ARFID (CBT-AR), family-based treatment (for children), gradual food exposure, and addressing underlying anxiety. Severe cases may require medical stabilization or feeding tubes. Nutritional rehabilitation is essential but must be guided by a team (physician, dietitian, therapist). Supplements address deficiencies but do not treat the underlying disorder. Never force foods or create negative mealtime experiences.

* Comprehensive Multivitamin is important because restricted eating typically leads to multiple micronutrient deficiencies. A high-quality multivitamin helps fill nutritional gaps while working on expanding the diet.

* Vitamin D deficiency is very common in ARFID due to limited food variety. It's essential for bone health, especially in growing children, and has roles in immune function and mood.

* Iron deficiency is common when protein sources are limited. Iron is critical for growth, cognitive development, and energy levels.

* Zinc deficiency can actually worsen the problem by affecting taste perception and appetite. Supplementation may help improve interest in food and taste sensitivity.

* Calcium intake is often inadequate when dairy products are avoided. This is especially concerning for bone development in children and adolescents.

* Vitamin B12 may be low if animal products are avoided. B12 is essential for neurological development and function.

* Omega-3 Fatty Acids are important for brain development and may help with the anxiety that often accompanies ARFID. Liquid or chewable forms may be better accepted.

* Probiotics can help support gut health, which may be compromised by limited dietary variety. GI symptoms are common in ARFID and may contribute to food avoidance.

Expected timeline: Nutritional repletion: ongoing throughout treatment. Zinc effects on appetite: 2-4 weeks. ARFID treatment is typically long-term (months to years) with gradual food exposure.

Clinical Perspective

ARFID (DSM-5): eating disturbance with weight loss, nutritional deficiency, dependence on supplements/enteral feeding, or psychosocial impairment. NOT due to body image concerns, cultural practice, or lack of food access. Presentations: sensory sensitivity (texture/taste aversion), lack of interest in eating, fear of aversive consequences (choking, vomiting). Common comorbidities: autism spectrum disorder, anxiety disorders, ADHD, OCD. Onset often in childhood; may persist into adulthood.

CRITICAL: Medical stabilization if significantly malnourished - refeeding syndrome risk. Multidisciplinary treatment: physician, dietitian, mental health provider. Evidence-based treatments: CBT-AR (adults/adolescents), family-based treatment (children). Exposure therapy for food fears. Address sensory issues (occupational therapy). Psychiatric comorbidities: anxiety treatment may help. Supplements address deficiencies during recovery; do NOT treat underlying disorder. Feeding tubes for severe cases.

* Multivitamin (B-grade): Multiple deficiencies common. Review: nutritional rehabilitation essential (PMID: 27453549). Study: micronutrient deficiencies in ARFID (PMID: 30054048). High-potency formula.

* Vitamin D (B-grade): Common deficiency in eating disorders. Systematic review: prevalence and consequences (PMID: 25623312). 2000-4000 IU based on levels.

* Iron (B-grade): Deficiency common with restricted protein. Review: clinical importance (PMID: 28155258). Supplement based on labs.

* Zinc (B-grade): Affects taste, appetite. Systematic review: zinc supplementation may improve appetite (PMID: 24561774). 15-30mg daily.

* Calcium (B-grade): Often inadequate; bone health concerns. Guidelines: calcium supplementation in eating disorders (PMID: 26857821). 500-1000mg daily.

* Vitamin B12 (C-grade): Risk if animal products avoided. Case series: deficiency in restrictive eating (PMID: 28756816). 500-1000mcg if deficient.

* Omega-3 Fatty Acids (C-grade): Brain health; may reduce anxiety. Review: omega-3 in eating disorders (PMID: 26281720). 1-2g EPA+DHA daily.

* Probiotics (C-grade): Gut-brain axis; microbiome affected by restriction. Review: gut microbiome and eating (PMID: 28411170). 10-20 billion CFU.

Biomarker targets: CBC (anemia), ferritin, B12, folate, zinc, vitamin D, calcium, phosphorus, magnesium, albumin, prealbumin, comprehensive metabolic panel, bone density (if prolonged restriction).

Protocol notes: Refeeding syndrome risk: monitor phosphorus, magnesium, potassium when refeeding after severe restriction. Start low, advance slowly. CBT-AR: systematic hierarchy exposure, address fear and avoidance. Family-based treatment: parental empowerment, structured meals. Sensory approaches: food chaining (gradual introduction of similar textures/flavors). DO NOT force feeding - creates aversive associations. Positive mealtime environment. Address GI symptoms (common in ARFID). Consider underlying conditions: celiac disease, eosinophilic esophagitis, reflux. School accommodations may be needed. Supplement forms: consider liquid, chewable, or gummy forms for sensory-sensitive individuals. Monitor growth in children. Long-term follow-up - many improve but some require ongoing support.

View All Protocols